Quantcast

Latest pharmaceutical industry Stories

2014-09-23 08:32:14

COSTA MESA, Calif., Sept. 23, 2014 /PRNewswire-iReach/ -- WCCT Global, a full service contract research organization headquartered in Southern California that is known for their on-time completion of clinical trials, announced today the successful completion of a Chinese ethnobridging clinical trial. WCCT Global was asked to quickly enroll 18, 1st generation Chinese volunteers into a clinical trial which required these subjects to stay in-house for 17 days. Successful completion of...

2014-09-23 08:31:59

TORONTO, Sept. 23, 2014 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce that its wholly owned subsidiary, Portage Pharmaceuticals Ltd (PPL) has added two more consultants to its team for further development of its PPL-003 for uveitis. PPL-003 uses a new proprietary cell permeable peptide platform technology derived from human genes to deliver its anti-inflammatory cargo into the eye. Ms....

2014-09-23 08:25:54

-- Global sales and marketing consulting firm ZS uncovers best new ways for pharmaceutical companies to communicate with physicians in new AffinityMonitor(TM) report -- EVANSTON, Ill., Sept. 23, 2014 /PRNewswire/ -- As physicians seek information about drugs today, increasingly more look to digital communication channels to learn about new therapies or ask questions of pharmaceutical companies. This finding - from a new report by global sales and marketing consultants at ZS - shows...

2014-09-23 04:22:02

AACHEN, Germany and BRUSSELS, September 23, 2014 /PRNewswire/ -- Young scientists from any European member country of the European Pain Federation EFIC(R) are invited to apply for the EFIC-Gruenenthal Grant (E-G-G) 2014. This grant is one of the most prestigious and highly regarded pain research grants worldwide. Provided by the European Pain Federation EFIC(R)in conjunction with the pharmaceutical company and pain expert Gruenenthal GmbH, the grant supports young...

2014-09-23 04:21:52

CAMBRIDGE, England, September 23, 2014 /PRNewswire/ -- New spin-out from Cancer Research UK launched with funding from Imperial Innovations, Cambridge Innovation Capital and Johnson & Johnson Development Corporation Inivata, a clinical cancer genomics company focused on harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment, today announced it has raised GBP4m in a funding round led by Imperial Innovations...

2014-09-22 23:08:15

CETICS Healthcare Technologies and Legal Science Partners have taken office space while HaRo Pharmaceutical and Hyalo Technologies have each established laboratory operations at the Port’s facilities at 37th and Market Streets. Philadelphia, PA (PRWEB) September 22, 2014 What do legal text coding, nanotechnology drug delivery and the simplification of in-vitro diagnostics have in common? All are being researched and developed by the newest residents of the Science Center’s Port...

2014-09-22 16:28:59

DUBLIN, September 22, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/94pdq3/global) has announced the addition of the "Global Biotechnology Reagents Market 2014-2018" [http://www.researchandmarkets.com/research/94pdq3/global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Biotechnology reagents are chemical compounds or substances that are added to a system to detect and examine...

2014-09-22 12:28:43

ELLICOTT CITY, Md., Sept. 22, 2014 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) has announced that its Good Clinical Practice (GCP) training, provided to all SCRS member employees, is now officially recognized by TransCelerate BioPharma Inc.'s members. Among TransCelerate's numerous members are SCRS Global Impact Partner companies AstraZeneca, Lilly, GlaxoSmithKline, Pfizer, Roche, and Sanofi. This landmark development is the result of considerable effort on behalf...

2014-09-22 12:26:18

Opportunities Will Be Driven By Projected Annual Growth Trend of 11.3 Percent Over the Next Five Years, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept. 22, 2014 /PRNewswire/ -- Decision Resources Group finds that by the end of 2014, the Chilean pharmaceutical market is expected to be worth $2 billion (U.S. dollars), increasing at a compound annual growth rate of 11.3 percent over the next five years (to 2018). This growth comes as Chile experienced GDP growth of...

2014-09-22 08:29:30

ABERDEEN, Scotland and SINGAPORE, Sept. 22, 2014 /PRNewswire/ -- TauRx Therapeutics Ltd has achieved its target enrolment of 700 subjects with mild Alzheimer's disease into the second of its two Phase III clinical trials of LMTX(TM), a tau aggregation inhibitor, for the treatment of Alzheimer's disease. This multi-centre, placebo-controlled clinical trial (Protocol TRx-237-005) is aimed at assessing the efficacy of LMTX(TM) in people diagnosed with mild Alzheimer's disease. The study...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related